Steve N. Slilaty
2022
In 2022, Steve N. Slilaty earned a total compensation of $370K as Chief Executive Officer and Director at Sunshine Biopharma, a 20% decrease compared to previous year.
Compensation breakdown
| Bonus | $10,000 |
|---|---|
| Salary | $360,000 |
| Total | $370,000 |
Slilaty received $360K in salary, accounting for 97% of the total pay in 2022.
Slilaty also received $10K in bonus.
Rankings
In 2022, Steve N. Slilaty's compensation ranked 4,757th out of 5,648 executives tracked by ExecPay. In other words, Slilaty earned more than 15.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,757 out of 5,648 | 16th |
Division Manufacturing | 2,639 out of 3,071 | 14th |
Major group Chemicals And Allied Products | 1,237 out of 1,386 | 11th |
Industry group Drugs | 1,162 out of 1,287 | 10th |
Industry Pharmaceutical Preparations | 842 out of 930 | 10th |
Source: SEC filing on October 18, 2023.
Slilaty's colleagues
We found two more compensation records of executives who worked with Steve N. Slilaty at Sunshine Biopharma in 2022.